Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia
This study will compare the effectiveness of newer atypical antipsychotics versus older conventional antipsychotics in treating schizophrenia.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
|Official Title:||Effectiveness of Atypical Vs Conventional Antipsychotics|
- EPS, TD.
|Primary Completion Date:||December 2002 (Final data collection date for primary outcome measure)|
At seven participating hospitals, acutely exacerbated patients with schizophrenia were randomly assigned to treatment with antipsychotic from the atypical class vs antipsychotic from the conventional class. Medication choice within class, dose, concomitant medications, and other prescribing decisions were left to the community prescriber. Patients were followed for one year after discharge.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00237861
|Principal Investigator:||Scott W Woods, MD||Yale University|